Putnam BioRevolution ETF
SYNB
SYNB
5 hedge funds and large institutions have $7.03M invested in Putnam BioRevolution ETF in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GT
Glenview Trust
Louisville,
Kentucky
|
+$2.01M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$607K |
| 3 |
Jane Street
New York
|
+$441K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.26K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PI
1
Putnam Investments
Boston,
Massachusetts
| $3.64M | – | – | – |
|
|
GT
2
Glenview Trust
Louisville,
Kentucky
| $2.01M | +$2.01M | +69,185 | New |
|
|
3
Jane Street
New York
| $766K | +$441K | +15,149 | +136% |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $610K | +$607K | +20,841 | +17,966% |
|
|
5
UBS Group
Zurich,
Switzerland
| $3.26K | +$3.26K | +112 | New |
|